The role of Notch signaling in T cell function
The role of Notch signaling in T cell function
批准号:
7320659
负责人:
BARBARA A OSBORNE
金额:
$32.17万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-12-01 至 2009-11-30
关键词:
AddressAutomobile DrivingBinding ProteinsBiological ModelsBrucella abortusCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCategoriesCell Cycle ProgressionCell LineageCell physiologyCellsComplexCyclinsDataDevelopmentEventFamily memberGene ExpressionHumanIL2RA geneImmune responseInfectionInterferon Type IIInterferonsKineticsLigandsLymphoidMediatingMembraneMusMutant Strains MiceMutationNF-kappa BOncogenicPatternPeripheralProductionProtein FamilyProteinsReceptor SignalingRegulationRoleSignal PathwaySignal TransductionSuggestionT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTestingTimecyclin D2cyclin D3cytokinedesignimmunological synapsein vivoinhibitor/antagonistinsightlymphoid neoplasmnotch proteinpathogenpresenilinprotein degradationreceptorresearch studyresponse
中文摘要
描述(由申请人提供):Notch蛋白家族由四个高度保守的膜受体组成。这些蛋白中至少有三种,Notch1, Notch2和Notch3,在淋巴细胞发育的不同时期表达。在正常情况下,Notch的表达指导T细胞谱系的发育。Notch基因的异常表达可导致T淋巴样肿瘤,提示该基因的表达可参与致癌转化。本文提出的初步数据表明,通过T细胞受体(TCR)的信号传导诱导notch依赖性信号通路的表达和激活。为了确定tcr诱导的外周T细胞Notch表达的后果,研究了表达反义Notch结构(Notch AS)的小鼠。此外,Notch激活的药理学抑制剂被用来抑制Notch活性。使用这两种方法,数据显示Notch激活是tcr诱导T细胞CD4和CD8亚群增殖所必需的。根据我们的初步数据,我们假设外周T细胞中的Notch信号具有几个重要的后果。首先,在CD4和CD8 T细胞中,Notch信号驱动细胞因子的产生和增殖。我们还提出了通过TCR调节Notch表达并导致NF-kB激活的特定信号通路。我们提出Notch是CD8 T细胞中NF-kB活性和ifn - γ产生所必需的,并提出NF-kB可能直接调节CD8细胞中ifn - γ的产生。我们还提出Notch是Th1功能所必需的,或者通过参与初始CD4细胞向Th1的极化,或者通过驱动Th1细胞因子在极化后的产生。我们的数据还支持Notch在CD4+、CD25-亚群与CD4+、CD25+亚群中的差异激活的作用,并表明Notch在这些重要的CD4 T细胞亚群中的表达可能具有功能后果。最后,我们提出Notch可能通过激活细胞周期蛋白D2和D3来调节T细胞的细胞周期进程。提出了四个目标来解决所提出的假设。目的1询问TCR信号如何调节Notch激活。Aim II询问Notch如何调节NF-kB。Aim III研究Notch激活在外周T细胞的功能后果,Aim IV研究Notch如何调节T细胞的细胞周期进程。
英文摘要
DESCRIPTION (provided by applicant): The Notch family of proteins is comprised of four highly conserved membrane receptors. At least three of these proteins, Notch1, Notch2 and Notch3, are expressed at various times during lymphoid development. Under normal circumstances, Notch expression directs the development of the T cell lineage. Aberrant Notch expression results in T lymphoid tumors suggesting the expression of this gene can participate in oncogenic transformation. Preliminary data presented in this proposal demonstrate that signaling via the T cell receptor (TCR) induces both the expression and activation of a Notch-dependent signaling pathway. To determine the consequences of TCR-induced Notch expression in peripheral T cells, mice expressing an antisense Notch construct (Notch AS) were examined. Additionally pharmacological inhibitors of Notch activation were used to inhibit Notch activity. Using these two approaches, data is presented demonstrating that Notch activation is required for TCR-induced proliferation of both CD4 and CD8 subsets of T cells. From our preliminary data, we hypothesize that Notch signaling in peripheral T cells has several important consequences. First of all, in both CD4 and CD8 T cells, Notch signaling drives cytokine production and proliferation. We also suggest a specific signaling pathway through the TCR that regulates Notch expression and results in activation of NF-kB. We propose that Notch is required for both NF-kB activity and IFN-gamma production in CD8 T cells and suggest that NF-kB may directly regulate IFN-gamma production in CD8 cells. We also propose that Notch is required for Th1 function either by participating in the polarization of naive CD4 cells into Th1 or by driving Th1 cytokine production following polarization. Our data also support a role for differential Notch activation in the CD4+, CD25- subset versus the CD4+, CD25+ subset and suggest that Notch expression in these important CD4 T cell subsets may have functional consequences. Lastly we propose that Notch may regulate cell cycle progression in T cells through activation of cyclin D2 and D3. Four aims are proposed to address the hypotheses presented. Aim I asks how TCR signaling regulates Notch activation. Aim II asks how Notch regulates NF-kB. Aim III examines the functional consequences of Notch activation in peripheral T cells and Aim IV asks how Notch regulates cell cycle progression in T cells.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4049/jimmunol.0802598
发表时间:
2009-03-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Cho OH, Shin HM, Miele L, Golde TE, Fauq A, Minter LM, Osborne BA]
通讯作者:
Osborne BA
DOI:
10.3389/fimmu.2014.00054
发表时间:
2014
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Dongre A, Surampudi L, Lawlor RG, Fauq AH, Miele L, Golde TE, Minter LM, Osborne BA]
通讯作者:
Osborne BA
Cellular Engineering Biotechnology Training Program
-
批准号:8794847
-
项目类别:
-
资助金额:$8.7万
-
财政年份:2015
-
负责人:BARBARA A OSBORNE
-
依托单位:
Targeting y-secretase in GVHD
-
批准号:8415152
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2013
-
负责人:BARBARA A OSBORNE
-
依托单位:
Targeting Multiple Diseases Through Gamma Secretase
-
批准号:8738618
-
项目类别:
-
资助金额:$92.28万
-
财政年份:2013
-
负责人:BARBARA A OSBORNE
-
依托单位:
Targeting Multiple Diseases Through Gamma Secretase
-
批准号:9040465
-
项目类别:
-
资助金额:$6.38万
-
财政年份:2013
-
负责人:BARBARA A OSBORNE
-
依托单位:
Administrative Core
-
批准号:8415154
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2013
-
负责人:BARBARA A OSBORNE
-
依托单位:
Targeting Multiple Diseases Through Gamma Secretase
-
批准号:8415150
-
项目类别:
-
资助金额:$98.08万
-
财政年份:2013
-
负责人:BARBARA A OSBORNE
-
依托单位:
Notch and TLRs Cross Paths in the Innate Immune System
-
批准号:8318163
-
项目类别:
-
资助金额:$5.26万
-
财政年份:2010
-
负责人:BARBARA A OSBORNE
-
依托单位:
Notch and TLRs Cross Paths in the Innate Immune System
-
批准号:7943669
-
项目类别:
-
资助金额:$5.96万
-
财政年份:2010
-
负责人:BARBARA A OSBORNE
-
依托单位:
Notch and TLRs Cross Paths in the Innate Immune System
-
批准号:8132992
-
项目类别:
-
资助金额:$5.26万
-
财政年份:2010
-
负责人:BARBARA A OSBORNE
-
依托单位:
Targeting Multiple Diseases Through Gamma Secretase
-
批准号:7258361
-
项目类别:
-
资助金额:$96.39万
-
财政年份:2006
-
负责人:BARBARA A OSBORNE
-
依托单位:
Targeting Multiple Diseases Through Gamma Secretase
-
批准号:7883268
-
项目类别:
-
资助金额:$95.41万
-
财政年份:2006
-
负责人:BARBARA A OSBORNE
-
依托单位:
Targeting Multiple Diseases Through Gamma Secretase
-
批准号:7018318
-
项目类别:
-
资助金额:$102.57万
-
财政年份:2006
-
负责人:BARBARA A OSBORNE
-
依托单位:
Targeting Multiple Diseases Through Gamma Secretase
-
批准号:8312931
-
项目类别:
-
资助金额:$11.63万
-
财政年份:2006
-
负责人:BARBARA A OSBORNE
-
依托单位:
Targeting Multiple Diseases Through Gamma Secretase
-
批准号:7458938
-
项目类别:
-
资助金额:$94.43万
-
财政年份:2006
-
负责人:BARBARA A OSBORNE
-
依托单位:
Targeting Multiple Diseases Through Gamma Secretase
-
批准号:7643198
-
项目类别:
-
资助金额:$95.38万
-
财政年份:2006
-
负责人:BARBARA A OSBORNE
-
依托单位:
IN VIVO EFFECTS OY Y-SECRETASE INHIBITION IN THE IMMUNE SYSTEM
-
批准号:7034749
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2005
-
负责人:BARBARA A OSBORNE
-
依托单位:
Polyclonal human antibody in cloned HAC-transgenic cows
-
批准号:6707459
-
项目类别:
-
资助金额:$38.46万
-
财政年份:2003
-
负责人:BARBARA A OSBORNE
-
依托单位:
Polyclonal human antibody in cloned HAC-transgenic cows
-
批准号:6831182
-
项目类别:
-
资助金额:$38.46万
-
财政年份:2003
-
负责人:BARBARA A OSBORNE
-
依托单位:
The role of Notch signaling in T cell function
-
批准号:6724072
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2003
-
负责人:BARBARA A OSBORNE
-
依托单位:
The role of Notch signaling in T cell function
-
批准号:7150019
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2003
-
负责人:BARBARA A OSBORNE
-
依托单位:
海外基金